肿瘤与膀胱壁接触长度可对VIRADS评分2-3的病灶进行有效风险分层
单中心回顾性研究纳入191例VIRADS评分2-3、经尿道电切术前接受MRI的患者,评估肿瘤接触长度(TCL)预测肌层浸润性膀胱癌(MIBC)的诊断效能。TCL与VIRADS评分均为MIBC的独立预测因子,TCL的敏感度、特异度、准确率和AUC均高于VIRADS评分。TCL可能有助于对VIRADS 2-3分患者进一步风险分层。
要点
- VIRADS评分2-3的病灶中,TCL是MIBC的独立预测因子,列线图中贡献大于VIRADS评分。
- 阈值3 cm时TCL敏感度0.89、特异度0.95、准确率0.94,AUC 0.97。
- VIRADS 2分病灶TCL较长或VIRADS 3分病灶TCL较短时,MIBC风险分别升高或降低。
核心结论
- TCL这一简单指标可能有助于对VIRADS评分2-3的患者进行MIBC的进一步风险分层。
研究设计与样本
- 单中心回顾性研究,纳入2019年7月至2021年9月连续191例VIRADS评分2-3且经尿道电切术前接受MRI的患者,采用逻辑回归分析MIBC预测因子并绘制列线图,以预设阈值(VIRADS 3分和TCL 3 cm)用广义线性模型和ROC分析比较诊断效能。
诊断标准与关键数值
- VIRADS评分预测MIBC的敏感度0.54(14/26)、特异度0.92(203/221)、准确率0.88(217/247);TCL预测MIBC的敏感度0.89(23/26)、特异度0.95(209/221)、准确率0.94(232/247)。
临床应用与阅片要点
- 对于VIRADS定性证据不足以判断肌层浸润的膀胱癌患者,TCL(定义为膀胱壁与肿瘤之间的曲线接触长度)可能有助于风险分层。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To evaluate the diagnostic performance of the tumor contact length (TCL) in the prediction of MIBC (muscle-invasive bladder cancer) in lesions corresponding to the vesical imaging-reporting and data system (VIRADS) score 2-3.
METHODS: This is a single institution, retrospective study targeting 191 consecutive patients assigned of VIRADS score 2-3, who had pre-transurethral resection MRI from July 2019 to September 2021. Logistic regression analyses were performed to determine meaningful predictors of MIBC for this score group, and a nomogram was plotted with those variables. The diagnostic performance of each predictor was compared at predefined thresholds (VIRADS score 3 and TCL 3 cm) using the generalized linear model and ROC analysis.
RESULTS: Both VIRADS score and TCL remained independent predictors of MIBC for this score group (odds ratio 7.3 for VIRADS score, and 1.3 for TCL, p < 0.01 for both). The contribution of TCL to the probability of MIBC in the nomogram was greater than that of the VIRADS score. VIRADS score had a sensitivity of 0.54 (14/26), specificity of 0.92 (203/221), and diagnostic accuracy of 0.88 (217/247), and TCL showed a sensitivity of 0.89 (23/26), specificity of 0.95 (209/221), and diagnostic accuracy of 0.94 (232/247). The difference in sensitivity (p = 0.03) and accuracy (p = 0.04) was statistically significant. The AUC was also significantly wider for TCL than for VIRADS (0.97 vs. 0.73, p < 0.01).
CONCLUSION: A simple index, TCL, may be helpful in further risk stratification for MIBC in patients with a score of VIRADS 2-3.
CLINICAL RELEVANCE STATEMENT: For bladder cancer patients with insufficient qualitative evidence of muscle layer invasion using VIRADS categorization, TCL, a simple quantitative indicator defined as the curvilinear contact length between the bladder wall and the tumor, may be helpful in risk stratification.
KEY POINTS: • Even when only lesions with score 2-3 were targeted, VIRADS was still a meaningful indicator of MIBC. • With a predefined threshold of 3 cm applied, TCL outperformed VIRADS in the score 2-3 group, in predicting MIBC. • A longer TCL for a lesion with a VIRADS score 2 may warrant an additional warning for MIBC, whereas a shorter TCL for a lesion with a score 3 may indicate a lower risk of MIBC.
引用
- Ahn H, Kim TM, Hwang SI, et al. Tumor contact length with bladder wall provides effective risk stratification for lesions with a VIRADS score of 2-3. Eur Radiol. 2023. PMID: 37438641. doi:10.1007/s00330-023-09925-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。